CureMatch, Inc. is a San Diego-based digital health company specializing in personalized medicine and combination therapy in oncology. The company operates in the healthcare technology sector, providing a decision support system that guides oncologists in selecting cancer drugs tailored to individual patients based on their molecular tumor profiles. CureMatch serves cancer patients, oncologists, and treatment centers, aiming to enhance the precision of cancer treatments. The business model revolves around offering a subscription-based service to healthcare providers, enabling them to access advanced cancer treatment options and actionable intelligence. Revenue is generated through these subscriptions and collaborations with pharmaceutical companies. Recently, CureMatch announced a collaboration with the Mark Cuban Cost Plus Drug Company to make cancer treatments more affordable and accessible to Americans.

Keywords: personalized medicine, oncology, decision support system, molecular tumor profiles, cancer treatment, healthcare technology, combination therapy, precision medicine, oncologists, digital health.